Mount Sinai Elementa Labs: First Year in ReviewJune 08, 2022
Take a look at the exciting updates from the inaugural year of Elementa Labs, Mount Sinai’s virtual incubator program.
Elementa Labs is currently accepting new applications for the Spring 2023 cohort until August 1. Learn more and apply here.
In May 2021, Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System, launched Elementa Labs, a virtual incubator program. The program aims to help pre-series A startup companies position themselves for their next major milestones by providing access to Mount Sinai’s key opinion leaders, subject matter experts, and other stakeholders to discover a potential path that could transform the participating company’s technology platforms while working closely with Mount Sinai.
The second cohort of Elementa is currently underway, which includes four startup companies. The first cohort, which consisted of three startup companies, completed the program in fall 2021.
These two cohorts tout a broad range of technology sectors and diverse founders of pre-Series A companies that aim to tackle some of the most pressing healthcare and biotechnology issues. Their solutions include: devices, digital therapeutics, information technologies, and printing platforms. Three companies are based, or have operations, in Canada, Ukraine, and Singapore. Each company has achieved success in varying forms during their participation in Elementa, such as launching new products, expanding partnerships, and raising their next round of financing.
- Key Personnel: Yair Saperstein, MD, MPH (CEO), Laurence Coman, MBA (COO)
- Description: Developed a platform to transform clinical content (such as guidelines and pathways) into digital, expert guidance at the point-of-care. The software is available on standalone web and mobile apps and in the EHR (now live on Epic’s App Orchard).
- Traction: Partners include Columbia Psychiatry, AstraZeneca, SUNY Downstate, Children’s Minnesota, Roche, the American Heart Association, KDIGO, HeartFlow, PM Pediatrics, and others. The company is raising its seed round in August.
- Curio Digital Therapeutics
- Key Personnel: Shailja Dixit, MD (CEO)
- Description: Developing digital therapeutics geared towards women’s behavioral health.
- Traction: Preparing for the development of several new product offerings. Raising funds for Series A round.
- Key Personnel: Miles Kilcourse, MS (CEO)
- Description: Creating devices to decrease the spread of infectious diseases, such as COVID-19.
- Traction: Preparing for key clinical pilots.
Spring 2022 (ongoing)
- Vivo Surgical
- Key Personnel: Kevin Koh, PhD (CEO)
- Description: A device company creating adaptable surgical tools to improve surgical performance, potentially including the world’s first disposable surgical robot for endoscopy.
- Traction: Its first commercialized product, a deep-cavity in vivo surgical lighting device co-developed with Panasonic, is now being distributed in over 25 international territories since going to market in 2021. Raising funds for Series A round.
- Empo Health
- Key Personnel: Anuj Khandelwal, MS, CEO & Eric Dahlseng, BS, Chief Product Officer
- Description: Using in-home remote patient monitoring to eliminate the severe diabetic foot ulcers suffered by 1 in 4 patients with diabetes, by solving the problem of patient compliance and giving physicians reliable eyes outside the clinic.
- Traction: Raising their Seed round and expanding their core team.
- Help Wear
- Key Personnel: Andre Bertram (CEO)
- Description: Building a continuous clinical grade ECG (heart) monitor for improved detection, prevention and treatment of heart-related illness, starting with cryptogenic stroke.
- Traction: Raising a Series A later this year.
Mount Sinai Champions and Stakeholders
Mount Sinai clinicians, investigators, administrators, and other stakeholders have generously participated as champions and key opinion leaders for the companies listed above. Each company is paired with a champion who develops potential collaborative projects and introduces the company to other key stakeholders at Mount Sinai. The involvement of the champions and stakeholders provides the company with insights into patient needs, hospital processes, regulatory paths, and more.
MSIP would like to thank all of our champions and stakeholders for their time and effort in working with participating companies and growing Elementa Labs!
- Aaron Patterson, MD, Associate Chief Medical Information Officer; Associate Professor, Psychiatry
- Alan Copperman, MD, Vice-Chairman, Obstetrics, Gynecology and Reproductive Sciences
- Abby Schwartz RN BSN MBA, Vice President, Network Development
- Arshad Rahim, MD, MBA, FACP, Vice President, Clinical Integration, Network Development & Population Health
- Alfred Marc Iloreta, MD, Director, Endoscopic Skull Base Surgery, Otolaryngology Head and Neck Surgery
- Benjamin Rappaport, MD, Scientific Director, Mount Sinai BioDesign Program
- Bruce Darrow, MD, Chief Medical Information Officer
- Bryan Markinson, DPM, Chief, Podiatric Medicine and Surgery, Dept. of Orthopedic Surgery
- Chelsea Canon, MD, Fellow, Reproductive, Endocrinology & Infertility
- Daniel Katz, MD, Attending Physician, Dept. of Anesthesiology
- Dara J. Lundon, MD, MBA, PhD, Director, Clinical Trials & Innovation, Dept. of Urology
- Darryl Hollar, MS, MBA, Director, Digital and Technology Partners
- Diana Kirke, MBBS MPhil FRACS, Assistant Professor, Otolaryngology Head and Neck Surgery
- Erik Lium, PhD, Chief Commercial Innovation Officer at Mount Sinai and President of Mount Sinai Innovation Partners
- Kristin Myers, Chief Information Officer, Digital and Technology Partners
- Leesa Galatz, MD, Chair of Orthopedic Surgery
- Michael Berger, MSBA, Chief Data & Analytics Officer
- Nihir Patel, MD, Attending Physician, Dept. of Anesthesiology
- Ronald Tamler, MD, PhD, MBA, Director of Health Implementation
- Robert Fields, MD, Executive Vice President, Chief Population Health Officer
- Robbie Freeman, RN, System Vice President & Chief Nursing Informatics Officer
- Ricardo Somarriba, Associate Director, Digital and Technology Partners
- Vivek Reddy, MD, Professor, Cardiology; Director of Cardiac Arrhythmia Services